• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513740
Device Problems Failure to Advance (2524); Appropriate Term/Code Not Available (3191)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/06/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(6).(b)(4).The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on july 10, 2020 that an ultraflex esophageal ng distal release covered stent was to be implanted to treat a malignant tumor in the esophagus during a stent placement procedure performed on (b)(6) 2020.Reportedly, the patient's anatomy was tortuous.According to the complainant, during the procedure post patient sedation, the stent was unable to cross the stenosis.Reportedly, the procedure was not completed due to device availability and the physician estimated that the patient may not endure a prolonged procedure.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Event Description
It was reported to boston scientific corporation on july 10, 2020 that an ultraflex esophageal ng distal release covered stent was to be implanted to treat a malignant tumor in the esophagus during a stent placement procedure performed on (b)(6) 2020.Reportedly, the patient's anatomy was tortuous.According to the complainant, during the procedure post patient sedation, the stent was unable to cross the stenosis.Reportedly, the procedure was not completed due to device availability and the physician estimated that the patient may not endure a prolonged procedure.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Block e1: initial reporter's facility name: (b)(6).Block h6: device problem code 3191 is being used to capture the reportable issue of aborted/cancelled procedure.Block h10: an ultraflex esophageal ng distal release covered stent and delivery system were received for analysis.The stent was returned fully covered and undeployed.Visual inspection was performed and it was found that the loops of the stent were bent.Functional evaluation revealed the stent was deployed without any issue by holding the handle hub in the palm of one hand, grasping and retracting the finger ring with the other hand.The outer diameter of the stent was measured and was found to be within specification.No other issues were noted to the stent and delivery system.The reported event of delivery system difficult to cross lesion was not confirmed, the issue occurred during the procedure and it is not possible to replicate in the laboratory.The investigation concluded that the reported event was likely due to factors encountered during the procedure.It may be that how the device was handled or manipulated, and/or the patient's tight anatomy, limited the performance of the device.Also, not lubricating the distal tip may contribute to the delivery system difficulty crossing the lesion.Additionally, the loops of the stent were bent; however, there is not sufficient information about what could be the cause for this failure.Therefore, a review and analysis of all available information indicated the most probable cause is no problem detected.A review of the device history record (dhr) was performed and confirmed that this device met all material, assembly, and performance specifications at the time of release for distribution.A labeling review was performed and from the information available, this device was used per the directions for use (dfu)/ product label.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key10349647
MDR Text Key209153801
Report Number3005099803-2020-03077
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729716167
UDI-Public08714729716167
Combination Product (y/n)N
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 09/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/09/2020
Device Model NumberM00513740
Device Catalogue Number1374
Device Lot Number0022496159
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/10/2020
Initial Date Manufacturer Received 07/10/2020
Initial Date FDA Received07/31/2020
Supplement Dates Manufacturer Received08/26/2020
Supplement Dates FDA Received09/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age70 YR
Patient Weight60
-
-